Ochiya T - Search Results

1

Development and biological analysis of peritoneal metastasis mouse models for human scirrhous stomach cancer.

Yanagihara K, Takigahira M, Tanaka H, Komatsu T, Fukumoto H, Koizumi F, Nishio K, Ochiya T, Ino Y, Hirohashi S. Yanagihara K, et al. Among authors: ochiya t. Cancer Sci. 2005 Jun;96(6):323-32. doi: 10.1111/j.1349-7006.2005.00054.x. Cancer Sci. 2005. PMID: 15958054 Free PMC article.

2

Hedgehog signal activation in gastric pit cell and in diffuse-type gastric cancer.

Fukaya M, Isohata N, Ohta H, Aoyagi K, Ochiya T, Saeki N, Yanagihara K, Nakanishi Y, Taniguchi H, Sakamoto H, Shimoda T, Nimura Y, Yoshida T, Sasaki H. Fukaya M, et al. Among authors: ochiya t. Gastroenterology. 2006 Jul;131(1):14-29. doi: 10.1053/j.gastro.2006.05.008. Gastroenterology. 2006. PMID: 16831586

3

Therapeutic potential of RNA interference against cancer.

Takeshita F, Ochiya T. Takeshita F, et al. Among authors: ochiya t. Cancer Sci. 2006 Aug;97(8):689-96. doi: 10.1111/j.1349-7006.2006.00234.x. Cancer Sci. 2006. PMID: 16863503 Free PMC article. Review.

4

A photon counting technique for quantitatively evaluating progression of peritoneal tumor dissemination.

Yanagihara K, Takigahira M, Takeshita F, Komatsu T, Nishio K, Hasegawa F, Ochiya T. Yanagihara K, et al. Among authors: ochiya t. Cancer Res. 2006 Aug 1;66(15):7532-9. doi: 10.1158/0008-5472.CAN-05-3259. Cancer Res. 2006. PMID: 16885351

5

RPN2 gene confers docetaxel resistance in breast cancer.

Honma K, Iwao-Koizumi K, Takeshita F, Yamamoto Y, Yoshida T, Nishio K, Nagahara S, Kato K, Ochiya T. Honma K, et al. Among authors: ochiya t. Nat Med. 2008 Sep;14(9):939-48. doi: 10.1038/nm.1858. Nat Med. 2008. PMID: 18724378

6

Antitumor effect of SN-38-releasing polymeric micelles, NK012, on spontaneous peritoneal metastases from orthotopic gastric cancer in mice compared with irinotecan.

Nakajima TE, Yanagihara K, Takigahira M, Yasunaga M, Kato K, Hamaguchi T, Yamada Y, Shimada Y, Mihara K, Ochiya T, Matsumura Y. Nakajima TE, et al. Among authors: ochiya t. Cancer Res. 2008 Nov 15;68(22):9318-22. doi: 10.1158/0008-5472.CAN-08-2822. Cancer Res. 2008. PMID: 19010905

7

Vandetanib (ZD6474), an inhibitor of VEGFR and EGFR signalling, as a novel molecular-targeted therapy against cholangiocarcinoma.

Yoshikawa D, Ojima H, Kokubu A, Ochiya T, Kasai S, Hirohashi S, Shibata T. Yoshikawa D, et al. Among authors: ochiya t. Br J Cancer. 2009 Apr 21;100(8):1257-66. doi: 10.1038/sj.bjc.6604988. Epub 2009 Mar 24. Br J Cancer. 2009. PMID: 19319137 Free PMC article.

8

MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma.

Yamamoto Y, Kosaka N, Tanaka M, Koizumi F, Kanai Y, Mizutani T, Murakami Y, Kuroda M, Miyajima A, Kato T, Ochiya T. Yamamoto Y, et al. Among authors: ochiya t. Biomarkers. 2009 Nov;14(7):529-38. doi: 10.3109/13547500903150771. Biomarkers. 2009. PMID: 19863192

9

Combined functional genome survey of therapeutic targets for hepatocellular carcinoma.

Satow R, Shitashige M, Kanai Y, Takeshita F, Ojima H, Jigami T, Honda K, Kosuge T, Ochiya T, Hirohashi S, Yamada T. Satow R, et al. Among authors: ochiya t. Clin Cancer Res. 2010 May 1;16(9):2518-28. doi: 10.1158/1078-0432.CCR-09-2214. Epub 2010 Apr 13. Clin Cancer Res. 2010. PMID: 20388846

10

Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis.

Kosaka N, Iguchi H, Ochiya T. Kosaka N, et al. Among authors: ochiya t. Cancer Sci. 2010 Oct;101(10):2087-92. doi: 10.1111/j.1349-7006.2010.01650.x. Epub 2010 Jul 7. Cancer Sci. 2010. PMID: 20624164 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

529 results

Search Page

Filters